{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T16:34:33Z","timestamp":1788798873395,"version":"build-2803163510"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,12]]},"DOI":"10.7759\/cureus.60158","type":"journal-article","created":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T00:42:44Z","timestamp":1715560964000},"source":"Crossref","is-referenced-by-count":5,"title":["Red Blood Cell Alloimmunization in Pregnancy: A Review of the Pathophysiology, Prevalence, and Risk Factors"],"prefix":"10.7759","author":[{"given":"Sanusi Nurul","family":"'Adani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noor Suryani","family":"Mohd Ashari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Farid","family":"Johan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisham Atan","family":"Edinur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noor Haslina","family":"Mohd Noor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Nazri","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.5581\/1516-8484.20120051","article-title":"Alloimmunization screening after transfusion of red blood cells in a prospective study","volume":"34","author":"Alves VM","year":"2012","unstructured":"Alves VM, Martins PR, Soares S, et al.. Alloimmunization screening after transfusion of red blood cells in a prospective study. Rev Bras Hematol Hemoter. 2012, 34:206-11. 10.5581\/1516-8484.20120051","journal-title":"Rev Bras Hematol Hemoter"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1159\/000501861","article-title":"Pathophysiology of alloimmunization","volume":"47","author":"Molina-Aguilar R","year":"2020","unstructured":"Molina-Aguilar R, G\u00f3mez-Ruiz S, Vela-Ojeda J, Montiel-Cervantes LA, Reyes-Maldonado E. Pathophysiology of alloimmunization. Transfus Med Hemother. 2020, 47:152-9. 10.1159\/000501861","journal-title":"Transfus Med Hemother"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.84211","article-title":"Alloimmunization and role of HLA in pregnancy","author":"Singh M","year":"2018","unstructured":"Singh M, Rajak J, Kadam S, Rajadhyaksha SB. Alloimmunization and role of HLA in pregnancy. Complications of Pregnancy. Abduljabbar H (ed): Intechopen, London, UK; 2018. 7:10.5772\/intechopen.84211"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/vox.13296","article-title":"Red blood cell alloimmunization among recipients of blood transfusion in India: a systematic review and meta-analysis","volume":"117","author":"Shastry S","year":"2022","unstructured":"Shastry S, Chenna D, Basavarajegowda A, Das S, Chaudhary RK. Red blood cell alloimmunization among recipients of blood transfusion in India: a systematic review and meta-analysis. Vox Sang. 2022, 117:1057-69. 10.1111\/vox.13296","journal-title":"Vox Sang"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24323","article-title":"Hemolytic disease of the fetus and newborn in the sensitizing pregnancy where anti-D was incorrectly identified as RhIG","volume":"36","author":"Walhof ML","year":"2022","unstructured":"Walhof ML, Leon J, Greiner AL, Scott JR, Knudson CM. Hemolytic disease of the fetus and newborn in the sensitizing pregnancy where anti-D was incorrectly identified as RhIG. J Clin Lab Anal. 2022, 36:e24323. 10.1002\/jcla.24323","journal-title":"J Clin Lab Anal"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1080\/00016340802268880","article-title":"Alloimmunization in pregnancy during the years 1992-2005 in the central west region of Sweden","volume":"87","author":"Gottvall T","year":"2008","unstructured":"Gottvall T, Filbey D. Alloimmunization in pregnancy during the years 1992-2005 in the central west region of Sweden. Acta Obstet Gynecol Scand. 2008, 87:843-8. 10.1080\/00016340802268880","journal-title":"Acta Obstet Gynecol Scand"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/trf.14508","article-title":"Risks of red blood cell alloimmunization in transfusion-dependent \u03b2-thalassemia in Oman: a 25-year experience of a university tertiary care reference center and a literature review","volume":"58","author":"Al-Riyami AZ","year":"2018","unstructured":"Al-Riyami AZ, Al-Muqbali A, Al-Sudiri S, et al.. Risks of red blood cell alloimmunization in transfusion-dependent \u03b2-thalassemia in Oman: a 25-year experience of a university tertiary care reference center and a literature review. Transfusion. 2018, 58:871-8. 10.1111\/trf.14508","journal-title":"Transfusion"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2017.1331124","article-title":"Neonatal management and outcome in alloimmune hemolytic disease","volume":"10","author":"Ree IM","year":"2017","unstructured":"Ree IM, Smits-Wintjens VE, van der Bom JG, van Klink JM, Oepkes D, Lopriore E. Neonatal management and outcome in alloimmune hemolytic disease. Expert Rev Hematol. 2017, 10:607-16. 10.1080\/17474086.2017.1331124","journal-title":"Expert Rev Hematol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4274\/tjh.galenos.2020.2019.0459","article-title":"Retrospective study on prevalence, specificity, sex, and age distribution of alloimmunization in two general hospitals in Athens","volume":"37","author":"Politou M","year":"2020","unstructured":"Politou M, Valsami S, Dryllis G, et al.. Retrospective study on prevalence, specificity, sex, and age distribution of alloimmunization in two general hospitals in Athens. Turk J Haematol. 2020, 37:154-66. 10.4274\/tjh.galenos.2020.2019.0459","journal-title":"Turk J Haematol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.acpath.2022.100040","article-title":"Educational case: alloimmunization of pregnancy","volume":"9","author":"Bastian IN","year":"2022","unstructured":"Bastian IN, Rose WN. Educational case: alloimmunization of pregnancy. Acad Pathol. 2022, 9:100040. 10.1016\/j.acpath.2022.100040","journal-title":"Acad Pathol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3889\/oamjms.2015.058","article-title":"Correlation between the amount of anti-D antibodies and IgG subclasses with severity of haemolytic disease of foetus and newborn","volume":"3","author":"Velkova E","year":"2015","unstructured":"Velkova E. Correlation between the amount of anti-D antibodies and IgG subclasses with severity of haemolytic disease of foetus and newborn. Open Access Maced J Med Sci. 2015, 3:293-7. 10.3889\/oamjms.2015.058","journal-title":"Open Access Maced J Med Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2015.1.146","article-title":"Hemolytic disease of the fetus and newborn: managing the mother, fetus, and newborn","volume":"2015","author":"Delaney M","year":"2015","unstructured":"Delaney M, Matthews DC. Hemolytic disease of the fetus and newborn: managing the mother, fetus, and newborn. Hematology Am Soc Hematol Educ Program. 2015, 2015:146-51. 10.1182\/asheducation-2015.1.146","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4103\/GJTM.GJTM_11_19","article-title":"Red cell alloimmunization in multi-transfused, oncology patients: risks and management","volume":"4","author":"Mangwana S","year":"2019","unstructured":"Mangwana S, Kacker A, Simon N. Red cell alloimmunization in multi-transfused, oncology patients: risks and management. Glob J Transfus Med. 2019, 4:74-8. 10.4103\/GJTM.GJTM_11_19","journal-title":"Glob J Transfus Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.33448\/rsd-v11i11.33555","article-title":"Frequency and specificity of erythrocyte alloimmunization in patients at a reference hospital in Alagoas, Brazil","volume":"11","author":"Barbosa KL","year":"2022","unstructured":"Barbosa KL, Lessa EEA, Soares MA, et al.. Frequency and specificity of erythrocyte alloimmunization in patients at a reference hospital in Alagoas, Brazil. Res Soc Dev. 2022, 11:1-10. 10.33448\/rsd-v11i11.33555","journal-title":"Res Soc Dev"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.5001\/omj.2020.95","article-title":"Prevalence of red blood cell alloimmunization among transfused chronic kidney disease patients in Hospital Universiti Sains Malaysia","volume":"35","author":"Yusoff SM","year":"2020","unstructured":"Yusoff SM, Bahar R, Hassan MN, Noor NH, Ramli M, Shafii NF. Prevalence of red blood cell alloimmunization among transfused chronic kidney disease patients in Hospital Universiti Sains Malaysia. Oman Med J. 2020, 35:e177. 10.5001\/omj.2020.95","journal-title":"Oman Med J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2016.1.452","article-title":"Cellular immune responses in red blood cell alloimmunization","volume":"2016","author":"Zimring JC","year":"2016","unstructured":"Zimring JC, Hudson KE. Cellular immune responses in red blood cell alloimmunization. Hematology Am Soc Hematol Educ Program. 2016, 2016:452-6. 10.1182\/asheducation-2016.1.452","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1159\/000368995","article-title":"Factors influencing RBC alloimmunization: lessons learned from murine models","volume":"41","author":"Ryder AB","year":"2014","unstructured":"Ryder AB, Zimring JC, Hendrickson JE. Factors influencing RBC alloimmunization: lessons learned from murine models. Transfus Med Hemother. 2014, 41:406-19. 10.1159\/000368995","journal-title":"Transfus Med Hemother"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13050886","article-title":"Red blood cell alloimmunization and its associated factors among chronic liver disease patients in a teaching hospital in northeastern Malaysia","volume":"13","author":"Siti SZ","year":"2023","unstructured":"Siti SZ, Hassan MN, Ramli M, Abdullah M, Mohd Noor NH. Red blood cell alloimmunization and its associated factors among chronic liver disease patients in a teaching hospital in northeastern Malaysia. Diagnostics (Basel). 2023, 13:886. 10.3390\/diagnostics13050886","journal-title":"Diagnostics (Basel)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.33140\/JCEI","article-title":"Cardiovascular manifestations and complications of pheochromocytomas and paragangliomas","volume":"3","author":"Siransy LK","year":"2018","unstructured":"Siransy LK, Romualde DS, Yeboah R, et al.. Cardiovascular manifestations and complications of pheochromocytomas and paragangliomas. J Clin Exp Immunol. 2018, 3:1-6. 10.33140\/JCEI","journal-title":"J Clin Exp Immunol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.4103\/joah.joah_122_21","article-title":"The prevalence of cumulative alloimmunization in patients with sickle cell disease at King Fahad University Hospital","volume":"13","author":"Aldawood RA","year":"2022","unstructured":"Aldawood RA. The prevalence of cumulative alloimmunization in patients with sickle cell disease at King Fahad University Hospital. J Appl Hematol. 2022, 13:35-40. 10.4103\/joah.joah_122_21","journal-title":"J Appl Hematol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3109\/00016349509021175","article-title":"The prevalence of red cell antibodies in pregnancy correlated to the outcome of the newborn: a 12 year study in central Sweden","volume":"74","author":"Filbey D","year":"1995","unstructured":"Filbey D, Hanson U, Wesstr\u00f6m G. The prevalence of red cell antibodies in pregnancy correlated to the outcome of the newborn: a 12 year study in central Sweden. Acta Obstet Gynecol Scand. 1995, 74:687-92. 10.3109\/00016349509021175","journal-title":"Acta Obstet Gynecol Scand"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1136\/fn.78.1.f62","article-title":"Consequences for fetus and neonate of maternal red cell allo-immunisation","volume":"78","author":"Howard H","year":"1998","unstructured":"Howard H, Martlew V, McFadyen I, Clarke C, Duguid J, Bromilow I, Eggington J. Consequences for fetus and neonate of maternal red cell allo-immunisation. Arch Dis Child Fetal Neonatal Ed. 1998, 78:F62-6. 10.1136\/fn.78.1.f62","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"ref23","article-title":"The clinical outcome of non-RhD antibody affected pregnancies in Northern Ireland","volume":"70","author":"Chandrasekar A","year":"2001","unstructured":"Chandrasekar A, Morris KG, Tubman TR, Tharma S, McClelland WM. The clinical outcome of non-RhD antibody affected pregnancies in Northern Ireland. Ulster Med J. 2001, 70:89-94.","journal-title":"Ulster Med J"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3148.2003.00445.x","article-title":"Prevalence and specificity of clinically significant red cell alloantibodies in Chinese women during pregnancy--a review of cases from 1997 to 2001","volume":"13","author":"Lee CK","year":"2003","unstructured":"Lee CK, Ma ES, Tang M, Lam CC, Lin CK, Chan LC. Prevalence and specificity of clinically significant red cell alloantibodies in Chinese women during pregnancy--a review of cases from 1997 to 2001. Transfus Med. 2003, 13:227-31. 10.1046\/j.1365-3148.2003.00445.x","journal-title":"Transfus Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.2450\/2011.0050-10","article-title":"The prevalence of irregular erythrocyte antibodies among antenatal women in Delhi","volume":"9","author":"Pahuja S","year":"2011","unstructured":"Pahuja S, Gupta SK, Pujani M, Jain M. The prevalence of irregular erythrocyte antibodies among antenatal women in Delhi. Blood Transfus. 2011, 9:388-93. 10.2450\/2011.0050-10","journal-title":"Blood Transfus"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2013.04.021","article-title":"The risk assessment study for hemolytic disease of the fetus and newborn in a University Hospital in Turkey","volume":"48","author":"Altuntas N","year":"2013","unstructured":"Altuntas N, Yenicesu I, Himmetoglu O, et al.. The risk assessment study for hemolytic disease of the fetus and newborn in a University Hospital in Turkey. Transfus Apher Sci. 2013, 48:377-80. 10.1016\/j.transci.2013.04.021","journal-title":"Transfus Apher Sci"},{"key":"ref27","article-title":"Red cell alloimmunization among antenatal women attending a tertiary care hospital in south India","volume":"138","author":"Varghese J","year":"2013","unstructured":"Varghese J, Chacko MP, Rajaiah M, Daniel D. Red cell alloimmunization among antenatal women attending a tertiary care hospital in south India. Indian J Med Res. 2013, 138:68-71.","journal-title":"Indian J Med Res"},{"key":"ref28","article-title":"Incidence of erythrocyte alloimmunization in pregnant women in Olomouc region","volume":"78","author":"Holuskov\u00e1 I","year":"2013","unstructured":"Holuskov\u00e1 I, Lubu\u0161k\u00fd M, Studni\u010dkov\u00e1 M, Proch\u00e1zka M. Incidence of erythrocyte alloimmunization in pregnant women in Olomouc region. \u010ces Gynek. 2013, 78:56-61.","journal-title":"\u010ces Gynek"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2014.12.002","article-title":"Risk of maternal alloimmunization in Southern Pakistan - a study in a cohort of 1000 pregnant women","volume":"52","author":"Karim F","year":"2015","unstructured":"Karim F, Moiz B, Kamran N. Risk of maternal alloimmunization in Southern Pakistan - a study in a cohort of 1000 pregnant women. Transfus Apher Sci. 2015, 52:99-102. 10.1016\/j.transci.2014.12.002","journal-title":"Transfus Apher Sci"},{"key":"ref30","article-title":"Red blood cell alloimmunization among Malay pregnant women: a tertiary hospital experience","volume":"22","author":"Hassan MN","year":"2015","unstructured":"Hassan MN, Haslina NNM, Noor SRJ, Ahmad Sukri S, Mustafa R. Red blood cell alloimmunization among Malay pregnant women: a tertiary hospital experience. Int J Med. 2015, 22:154-8.","journal-title":"Int J Med"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1097\/PAT.0000000000000225","article-title":"Prevalence of maternal red cell alloimmunisation: a population study from Queensland, Australia","volume":"47","author":"Pal M","year":"2015","unstructured":"Pal M, Williams B. Prevalence of maternal red cell alloimmunisation: a population study from Queensland, Australia. Pathology. 2015, 47:151-5. 10.1097\/PAT.0000000000000225","journal-title":"Pathology"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2016.06.002","article-title":"Red cell alloimmunization in RhD positive pregnant women and neonatal outcome","volume":"55","author":"Sankaralingam P","year":"2016","unstructured":"Sankaralingam P, Jain A, Bagga R, Kumar P, Marwaha N. Red cell alloimmunization in RhD positive pregnant women and neonatal outcome. Transfus Apher Sci. 2016, 55:153-8. 10.1016\/j.transci.2016.06.002","journal-title":"Transfus Apher Sci"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.20431\/2456-0561.0202005","article-title":"Prevalence of red blood cell alloantibodies in pregnant women and hemolytic disease of newborn in a tertiary care hospital","volume":"2","author":"Solves P","year":"2017","unstructured":"Solves P, Gomez-Segui I, Guinot M, et al.. Prevalence of red blood cell alloantibodies in pregnant women and hemolytic disease of newborn in a tertiary care hospital. ARC J Gynecol Obstet. 2017, 2:18-23. 10.20431\/2456-0561.0202005","journal-title":"ARC J Gynecol Obstet"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1111\/trf.14262","article-title":"Red blood cell alloimmunization in pregnancy during the years 1996-2015 in Iceland: a nation-wide population study","volume":"57","author":"Bollason G","year":"2017","unstructured":"Bollason G, Hjartardottir H, Jonsson T, Gudmundsson S, Kjartansson S, Halldorsdottir AM. Red blood cell alloimmunization in pregnancy during the years 1996-2015 in Iceland: a nation-wide population study. Transfusion. 2017, 57:2578-85. 10.1111\/trf.14262","journal-title":"Transfusion"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1007\/s13224-017-0984-5","article-title":"Frequency of red cell alloantibodies in pregnant females of Navsari district: an experience that favours inclusion of screening for irregular erythrocyte antibody in routine antenatal testing profile","volume":"68","author":"Kahar M","year":"2018","unstructured":"Kahar M. Frequency of red cell alloantibodies in pregnant females of Navsari district: an experience that favours inclusion of screening for irregular erythrocyte antibody in routine antenatal testing profile. J Obstet Gynaecol India. 2018, 68:300-5. 10.1007\/s13224-017-0984-5","journal-title":"J Obstet Gynaecol India"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.2147\/JBM.S214118","article-title":"Prevalence and specificity of clinically significant red cell alloantibodies in pregnant women - a study from a tertiary care hospital in Southeast Michigan","volume":"10","author":"Moinuddin I","year":"2019","unstructured":"Moinuddin I, Fletcher C, Millward P. Prevalence and specificity of clinically significant red cell alloantibodies in pregnant women - a study from a tertiary care hospital in Southeast Michigan. J Blood Med. 2019, 10:283-9. 10.2147\/JBM.S214118","journal-title":"J Blood Med"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.4103\/ajts.AJTS_105_18","article-title":"Distribution of antenatal alloimmunization in the southern districts of West Bengal and its significant associated factor","volume":"14","author":"Naik A","year":"2020","unstructured":"Naik A, Bhattacharya P, Das P, Mukherjee K, Mukhopadhyay P. Distribution of antenatal alloimmunization in the southern districts of West Bengal and its significant associated factor. Asian J Transfus Sci. 2020, 14:119-25. 10.4103\/ajts.AJTS_105_18","journal-title":"Asian J Transfus Sci"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.4103\/ajts.AJTS_72_17","article-title":"Red cell alloimmunization among antenatal women attending tertiary care center in Jamnagar, Gujarat, India","volume":"15","author":"Dholakiya SK","year":"2021","unstructured":"Dholakiya SK, Bharadva S, Vachhani JH, Upadhyay BS. Red cell alloimmunization among antenatal women attending tertiary care center in Jamnagar, Gujarat, India. Asian J Transfus Sci. 2021, 15:52-6. 10.4103\/ajts.AJTS_72_17","journal-title":"Asian J Transfus Sci"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.5468\/ogs.22190","article-title":"Red cell alloimmunization in pregnancy: a study from a premier tertiary care centre of Western India","volume":"66","author":"Gothwal M","year":"2023","unstructured":"Gothwal M, Singh P, Bajpayee A, Agrawal N, Yadav G, Sharma C. Red cell alloimmunization in pregnancy: a study from a premier tertiary care centre of Western India. Obstet Gynecol Sci. 2023, 66:84-93. 10.5468\/ogs.22190","journal-title":"Obstet Gynecol Sci"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.2298\/vsp201124016b","article-title":"Red blood cell alloimmunization in pregnancy: a 10-year single-center study","volume":"79","author":"Bujandric N","year":"2022","unstructured":"Bujandric N, Grujic J, Budakov-Obradovic Z. Red blood cell alloimmunization in pregnancy: a 10-year single-center study. Vojnosanit Pregl. 2022, 79:666-72. 10.2298\/vsp201124016b","journal-title":"Vojnosanit Pregl"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.5001\/omj.2011.113","article-title":"Fetomaternal transfusion as a cause of severe fetal anemia causing early neonatal death: a case report","volume":"26","author":"Ahmed M","year":"2011","unstructured":"Ahmed M, Abdullatif M. Fetomaternal transfusion as a cause of severe fetal anemia causing early neonatal death: a case report. Oman Med J. 2011, 26:444-6. 10.5001\/omj.2011.113","journal-title":"Oman Med J"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1515\/crpm-2021-0079","article-title":"Massive fetomaternal hemorrhage: a case series and review of literature","volume":"11","author":"Smet C","year":"2022","unstructured":"Smet C, Queir\u00f3 L, Santos E, Reis A, Costa C. Massive fetomaternal hemorrhage: a case series and review of literature. Case Reports in Perinatal Medicine. 2022, 11:10.1515\/crpm-2021-0079","journal-title":"Case Reports in Perinatal Medicine"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1296028","article-title":"Fetal-maternal hemorrhage: a case and literature review","volume":"2","author":"Solomonia N","year":"2012","unstructured":"Solomonia N, Playforth K, Reynolds EW. Fetal-maternal hemorrhage: a case and literature review. AJP Rep. 2012, 2:7-14. 10.1055\/s-0031-1296028","journal-title":"AJP Rep"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2020.102944","article-title":"Erythrocyte alloimmunity and genetic variance: results from the collaborative study of alloimmunity to antigen diversity in Asian populations (all ADP)","volume":"59","author":"Takeshita A","year":"2020","unstructured":"Takeshita A, Watanabe H, Yamada C, et al.. Erythrocyte alloimmunity and genetic variance: results from the collaborative study of alloimmunity to antigen diversity in Asian populations (all ADP). Transfus Apher Sci. 2020, 59:102944. 10.1016\/j.transci.2020.102944","journal-title":"Transfus Apher Sci"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0238844","article-title":"Antenatal and postpartum prevention of Rh alloimmunization: a systematic review and GRADE analysis","volume":"15","author":"Hamel C","year":"2020","unstructured":"Hamel C, Esmaeilisaraji L, Thuku M, Michaud A, Sikora L, Fung-Kee-Fung K. Antenatal and postpartum prevention of Rh alloimmunization: a systematic review and GRADE analysis. PLoS One. 2020, 15:e0238844. 10.1371\/journal.pone.0238844","journal-title":"PLoS One"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.2450\/2009.0108-09","article-title":"The role of antenatal immunoprophylaxis in the prevention of maternal-foetal anti-Rh(D) alloimmunisation","volume":"8","author":"Liumbruno GM","year":"2010","unstructured":"Liumbruno GM, D'Alessandro A, Rea F, et al.. The role of antenatal immunoprophylaxis in the prevention of maternal-foetal anti-Rh(D) alloimmunisation. Blood Transfus. 2010, 8:8-16. 10.2450\/2009.0108-09","journal-title":"Blood Transfus"},{"key":"ref47","article-title":"Approach to red blood cell antibody testing during pregnancy: answers to commonly asked questions","volume":"66","author":"Minuk L","year":"2020","unstructured":"Minuk L, Clarke G, Lieberman L. Approach to red blood cell antibody testing during pregnancy: answers to commonly asked questions. Can Fam Physician. 2020, 66:491-8.","journal-title":"Can Fam Physician"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1111\/tme.12299","article-title":"Guideline for blood grouping and red cell antibody testing in pregnancy","volume":"26","author":"White J","year":"2016","unstructured":"White J, Qureshi H, Massey E, Needs M, Byrne G, Daniels G, Allard S. Guideline for blood grouping and red cell antibody testing in pregnancy. Transfus Med. 2016, 26:246-63. 10.1111\/tme.12299","journal-title":"Transfus Med"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1542\/neo.14-2-e83","article-title":"Hemolytic disease of the fetus and newborn","volume":"14","author":"Ross MB","year":"2013","unstructured":"Ross MB, De Alarc\u00f3n P. Hemolytic disease of the fetus and newborn. NeoReviews. 2013, 14:c85-8. 10.1542\/neo.14-2-e83","journal-title":"NeoReviews"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.85316","article-title":"Hemolytic disease of the fetus and newborn","author":"Das S","year":"2019","unstructured":"Das S. Hemolytic disease of the fetus and newborn. Blood Group. Anil Tombak (ed): IntechOpen, Turkey; 2019. 1-20. 10.5772\/intechopen.85316"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2013.07.014","article-title":"Fetal blood sampling","volume":"209","author":"Berry SM","year":"2013","unstructured":"Berry SM, Stone J, Norton ME, Johnson D, Berghella V. Fetal blood sampling. Am J Obstet Gynecol. 2013, 209:170-80. 10.1016\/j.ajog.2013.07.014","journal-title":"Am J Obstet Gynecol"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2016.1.446","article-title":"Understanding red blood cell alloimmunization triggers","volume":"2016","author":"Hendrickson JE","year":"2016","unstructured":"Hendrickson JE, Tormey CA. Understanding red blood cell alloimmunization triggers. Hematology Am Soc Hematol Educ Program. 2016, 2016:446-51. 10.1182\/asheducation-2016.1.446","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1159\/000491788","article-title":"The recurrence risk of fetomaternal hemorrhage","volume":"45","author":"Tro\u00eca L","year":"2019","unstructured":"Tro\u00eca L, Al-Kouatly HB, McCurdy R, Konchak PS, Weiner S, Berghella V. The recurrence risk of fetomaternal hemorrhage. Fetal Diagn Ther. 2019, 45:1-12. 10.1159\/000491788","journal-title":"Fetal Diagn Ther"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.21037\/AOB-21-73","article-title":"Pregnancy and postpartum transfusion","volume":"7","author":"Linder GE","year":"2022","unstructured":"Linder GE, Ipe TS. Pregnancy and postpartum transfusion. Ann Blood. 2022, 7:10.21037\/AOB-21-73","journal-title":"Ann Blood"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1097\/GCO.0000000000000248","article-title":"Fetomaternal hemorrhage complicated pregnancy: risks, identification, and management","volume":"28","author":"Stefanovic V","year":"2016","unstructured":"Stefanovic V. Fetomaternal hemorrhage complicated pregnancy: risks, identification, and management. Curr Opin Obstet Gynecol. 2016, 28:86-94. 10.1097\/GCO.0000000000000248","journal-title":"Curr Opin Obstet Gynecol"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.17118","article-title":"Risk factors for RhD immunisation in a high coverage prevention programme of antenatal and postnatal RhIg: a nationwide cohort study","volume":"129","author":"Slootweg YM","year":"2022","unstructured":"Slootweg YM, Zwiers C, Koelewijn JM, van der Schoot E, Oepkes D, van Kamp IL, de Haas M. Risk factors for RhD immunisation in a high coverage prevention programme of antenatal and postnatal RhIg: a nationwide cohort study. BJOG. 2022, 129:1721-30. 10.1111\/1471-0528.17118","journal-title":"BJOG"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2011.10.004","article-title":"Red-cell and platelet alloimmunisation in pregnancy","volume":"26","author":"Egbor M","year":"2012","unstructured":"Egbor M, Knott P, Bhide A. Red-cell and platelet alloimmunisation in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2012, 26:119-32. 10.1016\/j.bpobgyn.2011.10.004","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i5789","article-title":"Sensitivity of fetal RHD screening for safe guidance of targeted anti-D immunoglobulin prophylaxis: prospective cohort study of a nationwide programme in the Netherlands","volume":"355","author":"de Haas M","year":"2016","unstructured":"de Haas M, Thurik FF, van der Ploeg CP, et al.. Sensitivity of fetal RHD screening for safe guidance of targeted anti-D immunoglobulin prophylaxis: prospective cohort study of a nationwide programme in the Netherlands. BMJ. 2016, 355:i5789. 10.1136\/bmj.i5789","journal-title":"BMJ"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-020-2742-4","article-title":"Targeted antenatal anti-D prophylaxis for RhD-negative pregnant women: a systematic review","volume":"20","author":"Runkel B","year":"2020","unstructured":"Runkel B, Bein G, Sieben W, Sow D, Polus S, Fleer D. Targeted antenatal anti-D prophylaxis for RhD-negative pregnant women: a systematic review. BMC Pregnancy Childbirth. 2020, 20:83. 10.1186\/s12884-020-2742-4","journal-title":"BMC Pregnancy Childbirth"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.2450\/2022.0004-22","article-title":"Prenatal screening service for fetal RHD genotyping to guide prophylaxis: the two-year experience of the Friuli Venezia Giulia region in Italy","volume":"21","author":"Londero D","year":"2023","unstructured":"Londero D, Merluzzi S, Dreossi C, Barillari G. Prenatal screening service for fetal RHD genotyping to guide prophylaxis: the two-year experience of the Friuli Venezia Giulia region in Italy. Blood Transfus. 2023, 21:93-9. 10.2450\/2022.0004-22","journal-title":"Blood Transfus"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.4103\/0973-6247.137449","article-title":"Hemolytic disease of fetus and newborn due to maternal red blood cell alloantibodies in the Malay population","volume":"8","author":"Hassan MN","year":"2014","unstructured":"Hassan MN, Mohd Noor NH, Johan Noor SR, Sukri SA, Mustafa R, Luc Aster HV. Hemolytic disease of fetus and newborn due to maternal red blood cell alloantibodies in the Malay population. Asian J Transfus Sci. 2014, 8:113-7. 10.4103\/0973-6247.137449","journal-title":"Asian J Transfus Sci"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.4103\/0973-6247.150968","article-title":"Maternal anti-M induced hemolytic disease of newborn followed by prolonged anemia in newborn twins","volume":"9","author":"Arora S","year":"2015","unstructured":"Arora S, Doda V, Maria A, Kotwal U, Goyal S. Maternal anti-M induced hemolytic disease of newborn followed by prolonged anemia in newborn twins. Asian J Transfus Sci. 2015, 9:98-101. 10.4103\/0973-6247.150968","journal-title":"Asian J Transfus Sci"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmrv.2022.12.009","article-title":"Alloantigen copy number as a critical factor in RBC alloimmunization","volume":"37","author":"Patel SR","year":"2023","unstructured":"Patel SR, Maier CL, Zimring JC. Alloantigen copy number as a critical factor in RBC alloimmunization. Transfus Med Rev. 2023, 37:21-6. 10.1016\/j.tmrv.2022.12.009","journal-title":"Transfus Med Rev"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.22254","article-title":"A novel laboratory technique demonstrating the influences of RHD zygosity and the RhCcEe phenotype on erythrocyte D antigen expression","volume":"87","author":"McGann PT","year":"2012","unstructured":"McGann PT, Despotovic JM, Howard TA, Ware RE. A novel laboratory technique demonstrating the influences of RHD zygosity and the RhCcEe phenotype on erythrocyte D antigen expression. Am J Hematol. 2012, 87:266-71. 10.1002\/ajh.22254","journal-title":"Am J Hematol"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics10080564","article-title":"Two reliable methodical approaches for non-invasive RHD genotyping of a fetus from maternal plasma","volume":"10","author":"Bohmova J","year":"2020","unstructured":"Bohmova J, Lubusky M, Holuskova I, et al.. Two reliable methodical approaches for non-invasive RHD genotyping of a fetus from maternal plasma. Diagnostics (Basel). 2020, 10:564. 10.3390\/diagnostics10080564","journal-title":"Diagnostics (Basel)"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.681","article-title":"Effects of RHD gene polymorphisms on distinguishing weak D or DEL from RhD- in blood donation in a Chinese population","volume":"7","author":"Shi J","year":"2019","unstructured":"Shi J, Luo Y. Effects of RHD gene polymorphisms on distinguishing weak D or DEL from RhD- in blood donation in a Chinese population. Mol Genet Genomic Med. 2019, 7:e00681. 10.1002\/mgg3.681","journal-title":"Mol Genet Genomic Med"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020002148","article-title":"A novel algorithm comprehensively characterizes human RH genes using whole-genome sequencing data","volume":"4","author":"Chang TC","year":"2020","unstructured":"Chang TC, Haupfear KM, Yu J, et al.. A novel algorithm comprehensively characterizes human RH genes using whole-genome sequencing data. Blood Adv. 2020, 4:4347-57. 10.1182\/bloodadvances.2020002148","journal-title":"Blood Adv"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.21037\/aob-23-10","article-title":"RH genotyping by next-generation sequencing","volume":"8","author":"Khandelwal A","year":"2023","unstructured":"Khandelwal A, Zittermann S, Sierocinski T, Montemayor C. RH genotyping by next-generation sequencing. Ann Blood. 2023, 8:30. 10.21037\/aob-23-10","journal-title":"Ann Blood"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1111\/voxs.12360","article-title":"Red blood cell alloimmunisation: induction of immunity and potential mitigation strategies","volume":"13","author":"Hendrickson JE","year":"2018","unstructured":"Hendrickson JE. Red blood cell alloimmunisation: induction of immunity and potential mitigation strategies. ISBT Sci Ser. 2018, 13:105-11. 10.1111\/voxs.12360","journal-title":"ISBT Sci Ser"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2015.10.010","article-title":"Protective effect of HLA-DQB1 alleles against alloimmunization in patients with sickle cell disease","volume":"77","author":"Tatari-Calderone Z","year":"2016","unstructured":"Tatari-Calderone Z, Gordish-Dressman H, Fasano R, et al.. Protective effect of HLA-DQB1 alleles against alloimmunization in patients with sickle cell disease. Hum Immunol. 2016, 77:35-40. 10.1016\/j.humimm.2015.10.010","journal-title":"Hum Immunol"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.12891\/ceog4480.2018","article-title":"HLA-DQB1\u22170201 phenotype and severe primary RhD immunization","volume":"45","author":"Giancotti A","year":"2018","unstructured":"Giancotti A, Pizzuti A, D\u2019Ambrosio V, et al.. HLA-DQB1\u22170201 phenotype and severe primary RhD immunization. Clin Exp Obstet Gynecol. 2018, 45:549-51. 10.12891\/ceog4480.2018","journal-title":"Clin Exp Obstet Gynecol"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-0465-0","article-title":"Antigen presentation by dendritic cells and their instruction of CD4+ T helper cell responses","volume":"17","author":"Hilligan KL","year":"2020","unstructured":"Hilligan KL, Ronchese F. Antigen presentation by dendritic cells and their instruction of CD4+ T helper cell responses. Cell Mol Immunol. 2020, 17:587-99. 10.1038\/s41423-020-0465-0","journal-title":"Cell Mol Immunol"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2021.06.003","article-title":"New insights into B cells as antigen presenting cells","volume":"70","author":"Ghosh D","year":"2021","unstructured":"Ghosh D, Jiang W, Mukhopadhyay D, Mellins ED. New insights into B cells as antigen presenting cells. Curr Opin Immunol. 2021, 70:129-37. 10.1016\/j.coi.2021.06.003","journal-title":"Curr Opin Immunol"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2017.03.003","article-title":"Regulation of memory B and plasma cell differentiation","volume":"45","author":"Shinnakasu R","year":"2017","unstructured":"Shinnakasu R, Kurosaki T. Regulation of memory B and plasma cell differentiation. Curr Opin Immunol. 2017, 45:126-31. 10.1016\/j.coi.2017.03.003","journal-title":"Curr Opin Immunol"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.680480","article-title":"HLA class I molecules as immune checkpoints for NK cell alloreactivity and anti-viral immunity in kidney transplantation","volume":"12","author":"Duygu B","year":"2021","unstructured":"Duygu B, Olieslagers TI, Groeneweg M, Voorter CE, Wieten L. HLA class I molecules as immune checkpoints for NK cell alloreactivity and anti-viral immunity in kidney transplantation. Front Immunol. 2021, 12:680480. 10.3389\/fimmu.2021.680480","journal-title":"Front Immunol"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2016.08.019","article-title":"Variation of maternal KIR and fetal HLA-C genes in reproductive failure: too early for clinical intervention","volume":"33","author":"Moffett A","year":"2016","unstructured":"Moffett A, Chazara O, Colucci F, Johnson MH. Variation of maternal KIR and fetal HLA-C genes in reproductive failure: too early for clinical intervention. Reprod Biomed Online. 2016, 33:763-9. 10.1016\/j.rbmo.2016.08.019","journal-title":"Reprod Biomed Online"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-061020-053702","article-title":"Cytokine regulation and function in T cells","volume":"39","author":"Dong C","year":"2021","unstructured":"Dong C. Cytokine regulation and function in T cells. Annu Rev Immunol. 2021, 39:51-76. 10.1146\/annurev-immunol-061020-053702","journal-title":"Annu Rev Immunol"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201040673","article-title":"IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro","volume":"40","author":"Bouaziz JD","year":"2010","unstructured":"Bouaziz JD, Calbo S, Maho-Vaillant M, Saussine A, Bagot M, Bensussan A, Musette P. IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro. Eur J Immunol. 2010, 40:2686-91. 10.1002\/eji.201040673","journal-title":"Eur J Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/245142-red-blood-cell-alloimmunization-in-pregnancy-a-review-of-the-pathophysiology-prevalence-and-risk-factors","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T00:42:53Z","timestamp":1715560973000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/245142-red-blood-cell-alloimmunization-in-pregnancy-a-review-of-the-pathophysiology-prevalence-and-risk-factors"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,12]]},"references-count":78,"URL":"https:\/\/doi.org\/10.7759\/cureus.60158","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,12]]}}}